Beil W J, Schulz M, Wefelmeyer U
Department of Pathology, Vienna University, Austria.
Histol Histopathol. 2000 Jul;15(3):937-46. doi: 10.14670/HH-15.937.
This review provides a survey on mast cell heterogeneity, with aspects differing in humans and rodents or which are subject of conflicting evidence being discussed in greater detail. Mast cell subsets have been first defined in rats by their fixation and dye-binding properties, and detailed studies in humans and pigs reveal very similar observations. The dye-binding properties of rat mast cell subsets are causally related to the absence or presence of heparin in their granules. In humans, this relation has not been shown. Rodent mast cell subsets store different chymase-isoforms. In contrast, just a single chymase has been defined in humans, and mast cells are classified by the presence or relative absence of this chymase. Different investigators find quite different proportions of chymase-positive to chymase-negative mast cells. Tryptase(s) are found in most or every human mast cell, but in rodents, they have hitherto been essentially localised to mast cells in connective tissues. Human mast cell subsets may also be defined by their expression of receptors such as C5aR and possibly the beta-chemokine receptor CCR3; the CCR3 expression seems to be related to the human mast cell chymase expression. Ultrastructural studies are helpful to distinguish human mast cell subsets, and allow to distinguish between chronic and acute activation. The phenotypical characteristics may change in association with inflammation or other disease processes. Studies in humans and pigs show changed dye-binding and fixation properties of the granules. Experimental rodent infection models reveal similar changes of chymase isoform expression. Human lung mast cells have been reported to strongly upregulate their chymase content in pulmonary vascular disease. This line of evidence can explain some inconsistent information on mast cell heterogeneity and may help to understand the physiological role of mast cells.
本综述对肥大细胞的异质性进行了概述,详细讨论了人类和啮齿动物之间存在差异或存在相互矛盾证据的方面。肥大细胞亚群最初是在大鼠中根据其固定和染料结合特性定义的,对人类和猪的详细研究也得出了非常相似的观察结果。大鼠肥大细胞亚群的染料结合特性与它们颗粒中肝素的有无有因果关系。在人类中,尚未发现这种关系。啮齿动物肥大细胞亚群储存不同的糜蛋白酶同工型。相比之下,人类仅定义了一种糜蛋白酶,肥大细胞根据这种糜蛋白酶的有无或相对缺乏进行分类。不同的研究者发现糜蛋白酶阳性和阴性肥大细胞的比例差异很大。大多数或所有人肥大细胞中都发现了类胰蛋白酶,但在啮齿动物中,迄今为止它们主要定位于结缔组织中的肥大细胞。人类肥大细胞亚群也可以根据它们对C5aR等受体的表达以及可能的β趋化因子受体CCR3的表达来定义;CCR3的表达似乎与人类肥大细胞糜蛋白酶的表达有关。超微结构研究有助于区分人类肥大细胞亚群,并区分慢性和急性激活。表型特征可能会随着炎症或其他疾病过程而改变。对人类和猪的研究表明颗粒的染料结合和固定特性发生了变化。实验性啮齿动物感染模型显示糜蛋白酶同工型表达有类似变化。据报道,人类肺肥大细胞在肺血管疾病中会强烈上调其糜蛋白酶含量。这一系列证据可以解释关于肥大细胞异质性的一些不一致信息,并可能有助于理解肥大细胞的生理作用。